These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27539619)

  • 1. Effect of pulmonary exacerbations treated with oral antibiotics on clinical outcomes in cystic fibrosis.
    Stanojevic S; McDonald A; Waters V; MacDonald S; Horton E; Tullis E; Ratjen F
    Thorax; 2017 Apr; 72(4):327-332. PubMed ID: 27539619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations.
    Waters V; Stanojevic S; Klingel M; Chiang J; Sonneveld N; Kukkar R; Tullis E; Ratjen F
    J Cyst Fibros; 2015 Nov; 14(6):770-6. PubMed ID: 26265220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis.
    Waters V; Atenafu EG; Salazar JG; Lu A; Yau Y; Matukas L; Tullis E; Ratjen F
    J Cyst Fibros; 2012 Jan; 11(1):8-13. PubMed ID: 21849265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term azithromycin therapy in patients with cystic fibrosis.
    Emiralioğlu N; Öztürk Z; Yalçın E; Doğru D; Özçelik U; Kiper N
    Turk J Pediatr; 2016; 58(1):34-40. PubMed ID: 27922234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations.
    West NE; Beckett VV; Jain R; Sanders DB; Nick JA; Heltshe SL; Dasenbrook EC; VanDevanter DR; Solomon GM; Goss CH; Flume PA;
    J Cyst Fibros; 2017 Sep; 16(5):600-606. PubMed ID: 28457954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.
    Sanders DB; Solomon GM; Beckett VV; West NE; Daines CL; Heltshe SL; VanDevanter DR; Spahr JE; Gibson RL; Nick JA; Marshall BC; Flume PA; Goss CH;
    J Cyst Fibros; 2017 Sep; 16(5):592-599. PubMed ID: 28460885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
    Heltshe SL; Goss CH; Thompson V; Sagel SD; Sanders DB; Marshall BC; Flume PA
    Thorax; 2016 Mar; 71(3):223-9. PubMed ID: 25911223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis.
    Hoppe JE; Wagner BD; Accurso FJ; Zemanick ET; Sagel SD
    J Cyst Fibros; 2018 Nov; 17(6):760-768. PubMed ID: 29921503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in lung function is associated with worse clinical outcomes in cystic fibrosis.
    Heinzmann-Filho JP; Pinto LA; Marostica PJ; Donadio MV
    J Bras Pneumol; 2015; 41(6):509-15. PubMed ID: 26785959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics.
    Pirzada OM; McGaw J; Taylor CJ; Everard ML
    J Cyst Fibros; 2003 Jun; 2(2):69-71. PubMed ID: 15463852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antimicrobial use in outpatient cystic fibrosis pulmonary exacerbation management: a single-center experience.
    Briggs EC; Nguyen T; Wall MA; MacDonald KD
    Clin Respir J; 2012 Jan; 6(1):56-64. PubMed ID: 21595857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for lung disease progression in children with cystic fibrosis.
    van Horck M; van de Kant K; Winkens B; Wesseling G; Gulmans V; Hendriks H; van der Grinten C; Jöbsis Q; Dompeling E
    Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29773689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous antibiotic use and exacerbation events in an adult cystic fibrosis centre: A prospective observational study.
    Hoo ZH; Bramley NR; Curley R; Edenborough FP; Walters SJ; Campbell MJ; Wildman MJ
    Respir Med; 2019; 154():109-115. PubMed ID: 31234038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.
    Regelmann WE; Schechter MS; Wagener JS; Morgan WJ; Pasta DJ; Elkin EP; Konstan MW;
    Pediatr Pulmonol; 2013 Jul; 48(7):649-57. PubMed ID: 22949088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis.
    Sanders DB; Bittner RC; Rosenfeld M; Redding GJ; Goss CH
    Pediatr Pulmonol; 2011 Apr; 46(4):393-400. PubMed ID: 20967845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary exacerbations and acute declines in lung function in patients with cystic fibrosis.
    Wagener JS; Williams MJ; Millar SJ; Morgan WJ; Pasta DJ; Konstan MW
    J Cyst Fibros; 2018 Jul; 17(4):496-502. PubMed ID: 29685810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.
    Hoppe JE; Wagner BD; Sagel SD; Accurso FJ; Zemanick ET
    BMC Pulm Med; 2017 Dec; 17(1):188. PubMed ID: 29228933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis.
    Wagener JS; Rasouliyan L; VanDevanter DR; Pasta DJ; Regelmann WE; Morgan WJ; Konstan MW;
    Pediatr Pulmonol; 2013 Jul; 48(7):666-73. PubMed ID: 22888106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients.
    Waters V; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
    J Cyst Fibros; 2013 Sep; 12(5):482-6. PubMed ID: 23294530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.